Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer

Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer

Purpose Immune checkpoint blockades (ICB) have been successful in gastric cancer (GC). However, the majority of unselected patients with GC fail to respond to ICB. It is crucial to identify precise biomarkers to predict response to ICB. Methods Gene expression profiling of formalin-fixed and paraffi...

Full description

Bibliographic Details
Main Authors: You Jeong Heo, So Young Kang, Seung Tae Kim, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
Format: Article
Language:English
Published: Sungkyunkwan University School of Medi 2019-12-01
Series:Precision and Future Medicine
Subjects:
biomarkers
pembrolizumab
prediction
response
stomach neoplasms
Online Access:http://www.pfmjournal.org/upload/pdf/pfm-2019-00079.pdf

Internet

http://www.pfmjournal.org/upload/pdf/pfm-2019-00079.pdf

Similar Items